Dafna Capital Management LLC Bio Xcel Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$17.62 - $58.71 $81,298 - $270,887	-4,614 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.26 - $41.14 $56,567 - $189,819	4,614 New	4,614 $103,000
Q4 2019 Feb 14, 2020	SELL	$4.05 - $14.61 $516,375 - $1.86 Million	-127,500 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.04 - $11.77 $897,600 - $1.5 Million	127,500 New	127,500 $898,000

3.11M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $8.69M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.